Press Release

Illumina to Webcast Live Presentation at the J.P. Morgan Annual Healthcare Conference

SAN DIEGO--(BUSINESS WIRE)--Dec. 28, 2015-- Illumina, Inc. (NASDAQ: ILMN) today announced that it will webcast the company’s presentation at the J.P. Morgan 34th Annual Healthcare Conference in San Francisco, California, on January 11, 2016. The live webcast is scheduled to begin at 11:00 AM PT and will feature an overview of the company by Jay Flatley, Chief Executive Officer, followed by a question and answer session.

The webcast can be accessed in the Investor Relations section of Illumina's web site under the "Company" tab at www.illumina.com.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.

Source: Illumina, Inc.

Illumina, Inc.
Investors:
Rebecca Chambers, 858-255-5243
rchambers@illumina.com
or
Media:
Jennifer Temple, 858-882-6822
pr@illumina.com

Recent Articles

The path to precision medicine in Indonesia
The path to precision medicine in Indonesia
It’s all about accessibility: Developing technical training for the MiSeq i100
It’s all about accessibility: Developing technical training for the MiSeq i100
The rare disease community fights for precision medicine, from diagnosis to cure
The rare disease community fights for precision medicine, from diagnosis to cure